Adrenal Insufficiency in ICU Patients
In ICU patients with suspected adrenal insufficiency, do not delay treatment to perform diagnostic testing—immediately administer hydrocortisone 100 mg IV bolus followed by 200 mg/24h (either as 50 mg IV every 6 hours or continuous infusion) in patients with vasopressor-dependent septic shock, while diagnostic testing offers limited clinical utility in guiding treatment decisions. 11
Diagnostic Approach
When to Suspect Critical Illness-Related Corticosteroid Insufficiency (CIRCI)
Suspect CIRCI in any hypotensive ICU patient who responds poorly to fluid resuscitation and vasopressors, particularly in septic shock. Key clinical clues include:
- Refractory hypotension despite adequate fluids and vasopressors
- Hyponatremia and hyperkalemia without clear alternative cause
- Unexplained hypoglycemia
- Persistent hemodynamic instability 2
Diagnostic Testing: Limited Clinical Utility
The 2017 SCCM/ESICM guidelines make no recommendation for or against using either the ACTH stimulation test (delta cortisol <9 μg/dL at 60 minutes after 250 μg cosyntropin) or random cortisol (<10 μg/dL) to diagnose CIRCI. 11 This represents a significant shift from 2008 recommendations, reflecting that:
- Clinicians have not adopted these diagnostic criteria in routine practice
- The Surviving Sepsis Campaign explicitly recommends against using ACTH stimulation testing to select patients for hydrocortisone treatment in septic shock 1
- The test does not predict who will benefit from corticosteroid therapy 3
Critical pitfall: Do not withhold corticosteroids while awaiting test results in vasopressor-dependent septic shock. If you must perform testing, use dexamethasone 4 mg initially (does not interfere with cortisol assays), then perform the ACTH stimulation test before switching to hydrocortisone 2.
Treatment Approach
Septic Shock with Vasopressor Dependence
Hydrocortisone 200 mg/day is recommended for patients with vasopressor-dependent septic shock, administered as:
- 50 mg IV every 6 hours, OR
- Continuous infusion at 200-240 mg/24h (approximately 10 mg/hour)
- Duration: Minimum 7 days 13
Do not use high-dose "pulse" corticosteroids (methylprednisolone ≥30 mg/kg/day)—these provide no benefit and may cause harm. 2
Acute Respiratory Distress Syndrome (ARDS)
For severe early ARDS (PaO₂/FiO₂ <200 within 14 days of onset):
- Methylprednisolone 1 mg/kg/day for ≥14 days 3
Adrenal Crisis Management
If frank adrenal crisis is suspected (severe hypotension, altered mental status, electrolyte abnormalities):
Immediate treatment:
- Hydrocortisone 100 mg IV bolus immediately
- 0.9% sodium chloride 10-20 mL/kg IV bolus, repeat as needed
- Monitor and correct hypoglycemia (target glucose >3.5 mmol/L)
- Start continuous hydrocortisone infusion 200 mg/24h or 50 mg IV every 6 hours 44
Fludrocortisone is not required acutely when high-dose hydrocortisone is given (hydrocortisone has mineralocorticoid activity at these doses). Add fludrocortisone 0.05-0.1 mg daily only when transitioning to maintenance therapy 44.
Weaning Strategy
Never stop corticosteroids abruptly in ICU patients. 3
Taper approach:
- Continue full stress doses until hemodynamically stable off vasopressors
- Gradually reduce over several days
- Monitor for recurrence of hypotension, worsening oxygenation, or sepsis signs
- Be prepared to reinstitute full doses if clinical deterioration occurs 3
Key Controversies and Nuances
The concept of "relative adrenal insufficiency" remains controversial 56. The 2017 guidelines deliberately use the term "critical illness-related corticosteroid insufficiency" to encompass both inadequate cortisol production and tissue corticosteroid resistance 1. The challenge is that no clinically useful test measures tissue glucocorticoid action, making diagnosis inherently problematic 5.
The evidence supports treatment based on clinical syndrome (vasopressor-dependent septic shock) rather than biochemical testing results. This pragmatic approach prioritizes mortality reduction over diagnostic precision 13.